27.51
08-10月-24 15:59:52
15 分の遅延
株式
+1.51
+5.81%
本日の幅
25.58 - 27.70
ISIN
N/A
ソース
NASDAQ
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
25 9 2024 07:08:51 提供 Nasdaq GlobeNewswire
Oruka Therapeutics Announces $200 Million Private Placement
12 9 2024 07:05:00 提供 Nasdaq GlobeNewswire
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
12 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
03 9 2024 07:00:00 提供 Nasdaq GlobeNewswire